Ligne de temps
Véronique Mayau
Technicien(ne)
01 janv. 2023
publication
Sec61 blockade therapy overrides resistance to proteasome inhibitors and immunomodulatory drugs in multiple myeloma.
Lire plus07 mars 2022
11 janv. 2022
news
New publication – The Sec61 translocon is a therapeutic vulnerability in multiple myeloma
Lire plus24 déc. 2021
publication
De novo synthesized polyunsaturated fatty acids operate as both host immunomodulators and nutrients for Mycobacterium tuberculosis.
Lire plus24 sept. 2020
publication